Materias dentro de su búsqueda.
Mostrando 4,061 - 4,080 Resultados de 4,918 Para Buscar '"Pfizer"', tiempo de consulta: 0.39s Limitar resultados
  1. 4061
    “…Kester, Sanofi: Employee, Salary. S. Faust, Pfizer, Merck, Sanofi, AstraZeneca/Medimmune: Scientific Advisor, all honoraria paid to institution with no personal payments of any kind.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    167. A Bordetella pertussis Human Challenge Model Induces Immunizing Colonization in the Absence of Symptoms
  2. 4062
    “…Schaffner, Merck: Member, Data Safety Monitoring Board, Consulting fee; Pfizer: Member, Data Safety Monitoring Board, Consulting fee; Dynavax: Consultant, Consulting fee; Seqirus: Consultant, Consulting fee; SutroVax: Consultant, Consulting fee; Shionogi: Consultant, Consulting fee.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
  3. 4063
    “…[Image: see text] [Image: see text] DISCLOSURES: S. Fridkin, Pfizer Inc.: Grant Investigator, Research support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1234. Racial Disparities in Invasive Staphylococcus aureus (iSA) Disease in Metropolitan Atlanta, a Population-Based Assessment, 2016
  4. 4064
    “…Merck: Investigator, Research support. Pfizer: Investigator, Research support. Protein Science: Investigator, Research support. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
  5. 4065
    “…[Image: see text] DISCLOSURES: E. Martin, Pfizer: Investigator, Salary.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    508. High Rates of Cure and Long-Term Symptom Resolution With Both Capsule and Lower Gastrointestinal Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
  6. 4066
    “…Shields, Allergan: Grant Investigator, Research grant. Pfizer: Consultant and Scientific Advisor, Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
  7. 4067
    “…Fowler Jr., Merck, Cerexa/Actavis, Pfizer, Advanced Liquid Logis, NIH, MedImmune, Basilea, Karius, Contrafect, Regneron, Genentech, Affinergy, Locus, Medical Surface, Inc., Achaogen, Astellas, Arsanis, Bayer, Cubist, Debiopharm, Durata, Grifols, Medicines Co, Novartis: Collaborator, Consultant and Scientific Advisor, Consulting fee, Research grant and Research support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
  8. 4068
    “…Shields, Allergan: Grant Investigator, Research grant. Pfizer: Consultant and Scientific Advisor, Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
  9. 4069
    “…Kontoyiannis, Merck: Consultant, Research support and Speaker honorarium. Pfizer: Consultant, Research support. Astellas: Consultant, Research support and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    359. Baseline Serum Aspergillus Galactomannan Index Among Aspergillus Species in Hematologic Malignancies Patients With Invasive Pulmonary Aspergillosis
  10. 4070
    “…Janssen: Grant Investigator and Scientific Advisor, Consulting fee, Grant recipient and Speaker honorarium. Pfizer: Consultant, Consulting fee and Speaker honorarium.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    261. Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
  11. 4071
    “…R.R. and M.M.H. have received educational grants and support for academic meetings from Pfizer, Roche, Novartis and Nabiqasim. A.H.Y. has been commissioned to provide lectures and advice to all major pharmaceutical companies with drugs used in affective and related disorders. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial
  12. 4072
    “…TRIAL REGISTRATION: NCT00413699, funded by Pfizer Inc (date of trial registration: December 20, 2006) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1866-2) contains supplementary material, which is available to authorized users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
  13. 4073
    “…Acknowledgment: This clinical study is conducted thanks to the competitive assignment of an Independent Grant for Learning & Change (“IGCL”) Dissemination & Implementation (“D&I”) by Pfizer Inc.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SUN-464 Trunk Fat Increase Is Prevented Both in Patients Undergoing Long-Lasting Continuous r-hGH Therapy and in Those Who Discontinued r-hGH Compared to Untreated Patients: Results from Baseline Data of the MAGHD Study
  14. 4074
    “…It was also supported initially by a grant from the Investigator Initiated Research (IIR) Program (WI177773) and by a non-restricted Research Grant from Pfizer Foundation to IB. Some of the pituitary acromegaly samples were collected in the framework of the Spanish National Registry of Acromegaly (REMAH), partially supported by an unrestricted grant from Novartis to the Spanish Endocrine Association (SEEN). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
  15. 4075
    “…TRIAL REGISTRATION: ClinicalTrials.gov, NCT02364999. FUNDING: Pfizer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40259-019-00363-4) contains supplementary material, which is available to authorized users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin(®)), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study
  16. 4076
    “…Downes, MD, Merck: Grant/Research Support, Research Grant; Pfizer: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1334. Performance of C-Reactive Protein and Procalcitonin in Immunocompromised Children with SIRS
  17. 4077
    “…These findings support currently recommended MenB-FHbp vaccination practices without modification by sex, age, or race. Funding: Pfizer [Image: see text] DISCLOSURES: All authors: No reported disclosures.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
  18. 4078
    “…ClinicalTrials.gov: NCT03189745, EudraCT # 2013-001512-29. Funded by Pfizer. [Image: see text] DISCLOSURES: All authors: No reported disclosures.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1478. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS
  19. 4079
    “…DISCLOSURES: Octavio Ramilo, MD, Bill & Melinda Gates Foundation: Research Grant; Janssen: Research Grant; Merck: Advisory Board; NIH: Research Grant; Ohio Children’s Hospital Association (OCHA): Research Grant; Pfizer: Advisory Board, Consultant, Lectures; Sanofi/Medimmune: Advisory Board.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
  20. 4080
    “…CLINICALTRIALS.GOV: NCT03189745, EudraCT # 2013-001512-29. Funded by Pfizer. [Image: see text] DISCLOSURES: All authors: No reported disclosures.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS
Herramientas de búsqueda: RSS